MX338891B - Nanoparticulas para encapsulacion de compuestos, su obtencion y uso. - Google Patents

Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.

Info

Publication number
MX338891B
MX338891B MX2013000636A MX2013000636A MX338891B MX 338891 B MX338891 B MX 338891B MX 2013000636 A MX2013000636 A MX 2013000636A MX 2013000636 A MX2013000636 A MX 2013000636A MX 338891 B MX338891 B MX 338891B
Authority
MX
Mexico
Prior art keywords
nanoparticles
encapsulation
compounds
production
liposoluble
Prior art date
Application number
MX2013000636A
Other languages
English (en)
Other versions
MX2013000636A (es
Inventor
Maite Agüeros Bazo
Juan Manuel Irache Garreta
Irene Esparza Catalán
Carolina González Ferrero
Carlos Javier González Navarro
Ana Romo Hualde
Original Assignee
Univ Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Navarra filed Critical Univ Navarra
Publication of MX2013000636A publication Critical patent/MX2013000636A/es
Publication of MX338891B publication Critical patent/MX338891B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S264/00—Plastic and nonmetallic article shaping or treating: processes
    • Y10S264/59—Processes in which a partial cure is involved

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)

Abstract

La presente invención se refiere a las nanopartículas comprenden una matriz de zeína y un aminoácido básico. Dichas nanopartículas pueden encapsular un compuesto biológicamente activo, hidrosoluble o liposoluble. De aplicación en los sectores alimentario, farmacéutico y cosmético y en el de la nanotecnología.
MX2013000636A 2010-07-16 2011-07-15 Nanoparticulas para encapsulacion de compuestos, su obtencion y uso. MX338891B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031095 2010-07-16
PCT/ES2011/070518 WO2012007628A1 (es) 2010-07-16 2011-07-15 Nanopartículas para encapsulación de compuestos, su obtención y usos

Publications (2)

Publication Number Publication Date
MX2013000636A MX2013000636A (es) 2013-05-31
MX338891B true MX338891B (es) 2016-05-04

Family

ID=44764176

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000636A MX338891B (es) 2010-07-16 2011-07-15 Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.

Country Status (14)

Country Link
US (1) US9381252B2 (es)
EP (1) EP2594140B1 (es)
JP (1) JP6046615B2 (es)
KR (1) KR101933024B1 (es)
CN (1) CN103037707B (es)
AU (1) AU2011278186B2 (es)
BR (1) BR112013000675B1 (es)
CA (1) CA2805581C (es)
DK (1) DK2594140T3 (es)
ES (1) ES2724176T3 (es)
MX (1) MX338891B (es)
PL (1) PL2594140T3 (es)
PT (1) PT2594140T (es)
WO (1) WO2012007628A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2625966A1 (en) * 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
JP6235779B2 (ja) * 2012-03-28 2017-11-22 株式会社コーセー 葉酸含有組成物及び葉酸の安定化方法
KR101362800B1 (ko) * 2012-10-16 2014-02-14 한국식품연구원 피토스테롤이 함유된 프롤라민-양이온 폴리머 복합체 및 이의 제조방법
GB201312245D0 (en) * 2013-07-08 2013-08-21 Gorman Eddie O An extrusion process
EP2856987A1 (en) 2013-10-07 2015-04-08 Absorbest AB A wound dressing and a method for manufacturing a wound dressing
AP2017009684A0 (es) 2014-08-11 2017-01-31
WO2016169942A1 (en) 2015-04-22 2016-10-27 Basf Se Nanoparticles, nanoemulsions and their formation with mixing chamber micronization
CN108308615A (zh) * 2018-01-12 2018-07-24 齐齐哈尔大学 一种玉米肽为载体的叶黄素纳米粒的制备方法
CN108576501B (zh) * 2018-01-18 2021-07-02 广东药科大学 一种植物多酚类功能饮料的制备方法
EP3581176A1 (en) 2018-06-12 2019-12-18 Universidad de Navarra Core-shell zein nanoparticles for the encapsulation of compounds, process for their preparation and uses thereof
CN112535212A (zh) * 2019-09-20 2021-03-23 内蒙古伊利实业集团股份有限公司 儿茶素原料的预处理方法以及包含儿茶素的果汁牛奶
CN111893584B (zh) * 2020-06-16 2021-06-22 杭州千芝雅卫生用品有限公司 耐水性环保纤维滤材及其制备方法
CN112370419A (zh) * 2020-10-16 2021-02-19 江苏大学 一种醇溶性蛋白、氨基酸或/和多糖协同稳定的Pickering乳液凝胶的制备方法
EP4267114A1 (en) 2020-12-23 2023-11-01 Universidad de Navarra Zein nanoparticles for use in hyperglycemic conditions
CN113244193A (zh) * 2021-04-26 2021-08-13 南京大学 用于递送甾醇及其衍生物的蛋白纳米粒的制法与应用
CN114129538B (zh) * 2021-10-26 2022-12-09 浙江科技学院 一种负载藏红花素玉米醇溶蛋白纳米颗粒的制备方法及应用
US20230149318A1 (en) * 2021-11-12 2023-05-18 NuRevelation, LLC Combinations of nanoparticle-encapsulated cargo entities and methods for making and using same
WO2023154838A2 (en) * 2022-02-11 2023-08-17 Arizona Board Of Regents On Behalf Of Arizona State University Antimicrobial materials and nanoparticles and methods of use thereof
US11559495B1 (en) * 2022-03-07 2023-01-24 King Abdulaziz University Icariin nano-pharmaceutical formulation
CN114796155B (zh) * 2022-03-31 2023-06-27 诺丁汉大学卓越灯塔计划(宁波)创新研究院 天然活性物质-玉米蛋白纳米颗粒及其制备方法和用途
CN116172115B (zh) * 2022-12-05 2024-05-14 西北农林科技大学 通过添加L-Lys改善高剂量EGCG对肉蛋白凝胶特性损伤的方法
CN116333079B (zh) * 2023-03-07 2023-09-15 中国农业科学院农产品加工研究所 一种用叶酸修饰的玉米醇溶蛋白及其制备方法和应用
CN116584652A (zh) * 2023-05-30 2023-08-15 蕴能(大连)生物科技有限公司 一种纳米级dha藻油冻干速溶片及其制备方法
CN117257737A (zh) * 2023-09-27 2023-12-22 青岛农业大学 一种多酚复合纳米颗粒、其制备方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550436A1 (en) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
JP3790567B2 (ja) * 1994-09-30 2006-06-28 武田薬品工業株式会社 徐放剤
FR2824756B1 (fr) 2001-05-16 2005-07-08 Mainelab Microcapsules a base de proteines vegetales
US20040086595A1 (en) 2002-10-31 2004-05-06 Jingping Liu Plasticized prolamine compositions
CN1717180A (zh) * 2002-11-29 2006-01-04 服洛因得产业股份有限公司 水性虫胶包膜材料、其制造方法、使用该包膜材料的包膜食品、其制造方法、包膜医药品、其制造方法、油性糖果的着色用组合物、着色方法、及着色油性糖果
JP2004269384A (ja) * 2003-03-06 2004-09-30 Kyowa Hakko Kogyo Co Ltd 吸水性アミノ酸被覆顆粒
CN1476825A (zh) * 2003-07-04 2004-02-25 中国科学院上海有机化学研究所 谷物类醇溶蛋白微球和制备方法
US20050244505A1 (en) 2003-12-11 2005-11-03 Higbee Russell G Immunotherapy compositions, method of making and method of use thereof
CN1562373A (zh) * 2004-03-25 2005-01-12 上海交通大学 植物源性醇溶蛋白微球固体剂型的制备方法
EP1928917A2 (en) 2005-09-09 2008-06-11 Kellogg Company Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
JP5806444B2 (ja) 2005-12-02 2015-11-10 ノバルティス アーゲー 免疫原性組成物で使用するためのナノ粒子
US20080305096A1 (en) * 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
EP2166874B1 (en) * 2007-06-19 2016-09-28 DSM IP Assets B.V. Microencapsulating compositions, methods of making, methods of using and products thereof
CN201092514Y (zh) 2007-06-25 2008-07-30 上海港机重工有限公司 双起升式集装箱起重机运行小车的吊具上架限位装置
CN100540608C (zh) * 2007-07-20 2009-09-16 浙江大学 谷类蛋白质/纳米粒子原位复合材料及其制备方法
WO2009067431A2 (en) 2007-11-20 2009-05-28 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
CN101485629B (zh) 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
EP2285825B1 (en) 2008-05-09 2020-07-15 South Dakota State University Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor

Also Published As

Publication number Publication date
PL2594140T3 (pl) 2019-09-30
KR20130045358A (ko) 2013-05-03
AU2011278186B2 (en) 2015-02-05
CN103037707A (zh) 2013-04-10
US20130116261A1 (en) 2013-05-09
US9381252B2 (en) 2016-07-05
EP2594140A1 (en) 2013-05-22
CN103037707B (zh) 2016-08-31
BR112013000675A2 (pt) 2016-05-31
JP6046615B2 (ja) 2016-12-21
WO2012007628A1 (es) 2012-01-19
DK2594140T3 (da) 2019-06-03
AU2011278186A1 (en) 2013-01-31
CA2805581C (en) 2018-10-02
KR101933024B1 (ko) 2018-12-27
CA2805581A1 (en) 2012-01-19
EP2594140B1 (en) 2019-03-20
JP2013532630A (ja) 2013-08-19
MX2013000636A (es) 2013-05-31
PT2594140T (pt) 2019-06-11
BR112013000675B1 (pt) 2021-07-20
RU2013106946A (ru) 2014-08-27
ES2724176T3 (es) 2019-09-06

Similar Documents

Publication Publication Date Title
MX2013000636A (es) Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.
MX2012009863A (es) Nanoparticulas para encapsulacion de compuestos, su preparacion y usos.
MX366411B (es) Microparticulas para encapsulacion de probioticos, su obtencion y usos.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX364537B (es) Producto para el cuidado oral y métodos de uso y fabricación del mismo.
IL216522A (en) Durable dosage form, packing containing it and method of preparation
PL2808325T3 (pl) Podstawione azole, przeciwwirusowy składnik czynny, kompozycja farmaceutyczna, sposób ich wytwarzania i stosowania
AP2010005490A0 (en) Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin.
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
WO2012035283A8 (en) Pharmaceutical composition
WO2011027258A3 (en) Scented capsules
IL221737A (en) Its compound or salt, a pharmaceutical preparation containing it and its uses
MX2013007014A (es) Metodo para la produccion de oxindoles sustituidos en el n con sulfonilo.
WO2015057820A3 (en) Peptide constructs and well-defined aggregates thereof
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
SG148120A1 (en) An oral pharmaceutical and an oral care product
WO2012108631A3 (en) Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
MX2013007000A (es) Proceso para encapsular ingrediente activo.
WO2011112100A8 (en) Peptide material, feed composition and preparations and uses thereof
MX2017007018A (es) Nanopartículas para encapsular compuestos, su preparación y sus usos.
AR089764A1 (es) Composicion farmaceutica de administracion oral de nitazoxanida, util para el tratamiento de infecciones parasitarias intestinales, y proceso para preparar granulos para suspension de nitazoxanida
LV14132A (lv) Suspensija, kas satur tehnoloģiski pārstrādātu dzintaru
UA91149C2 (en) nanocomposite material
UA100962C2 (ru) Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцина
MY153612A (en) Oral care product and methods of use and manufacture thereof

Legal Events

Date Code Title Description
FG Grant or registration